University of Texas/Texas AM Investment Management Co (UTIMCO)’s BridgeBio Pharma BBIO Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.45M	Buy	32,838 +17,146	+109%	+$1.2M	0.28%	57
2026 Q1	$1.17M	Buy	15,692 +7,265	+86%	+$527K	0.17%	86
2025 Q4	$645K	Sell	8,427 -3,140	-27%	-$206K	0.09%	112
2025 Q3	$601K	Buy	11,567 +2,446	+27%	+$119K	0.09%	95
2025 Q2	$394K	Buy	+9,121	New	+$332K	0.06%	86

Other funds holding BBIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s BBIO Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) increased its BridgeBio Pharma (BBIO) stake by 109% in Q2 2026, buying an estimated $1.2M and bringing the position to 32,838 shares worth $2.45M. The position accounts for 0.28% of the portfolio, ranked #57.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in BBIO in Q2 2025 and has held it in 5 quarters since. 277 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

University of Texas/Texas AM Investment Management Co (UTIMCO) held 32,838 shares of BridgeBio Pharma worth $2.45M as of Q2 2026.
University of Texas/Texas AM Investment Management Co (UTIMCO) bought 17,146 BridgeBio Pharma shares in Q2 2026, an estimated $1.2M.
BridgeBio Pharma made up 0.28% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #57 holding.
University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in BridgeBio Pharma in Q2 2025 and has held it in 5 quarters since.
277 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.